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Octopamine (OA) is a physiologically important invertebrate biogenic amine that has 
structural and functional similarities to the vertebrate biogenic amines adrenaline and 
noradrenaline. Following its initial discovery in octopus posterior salivary glands, OA 
was found in high concentrations in both neuronal and non-neuronal tissues of most 
invertebrate species studied. OA is synthesized by β-hydroxylation of tyramine (TA), 
which is a phenolamine synthesized from the amino acid tyrosine by decarboxylation. 
OA is engaged in sensory inputs, rhythmic behaviors, endocrine regulation, 
mobilization of lipids and carbohydrates, sleep and aggression as well as more complex 
physiological events, such as learning and memory, as a neurotransmitter, 
neuromodulator or neurohormone. 
 
The first insect OA receptor was isolated from the fruit fly Drosophila melanogaster. 
The OA receptor falls into the largest family (rhodopsin receptor family or family A) in 
the superfamily of G protein-coupled receptors (GPCRs), which share a common 
structural hallmark containing seven- transmembrane domains (TMs) and associated 
extracellular and intracellular loops (ICLs). The actions of OA are mediated by 
interactions with seven-transmembrane G protein-coupled receptors (GPCRs), which 
induce the production or release of intracellular second messengers such as cAMP and 
Ca2+ via the activation of discrete G proteins and linked effectors. Following the initial 
isolation in fruit flies, a variety of OA receptors were cloned from several other insect 
species. To classify the various OA receptors, Evans and Maqueira (2005) proposed a 
novel classification system in which OA receptors are designated as α-adrenergic-like 
OA receptors (OctαRs), β-adrenergic-like OA receptors (OctβRs) or OA/TA (or 
tyraminergic) receptors. This classification is based on the similarities of these proteins 
to vertebrate adrenergic receptors in terms of amino acid sequence and signaling 
pathway. Activation of α-adrenergic-like OA receptors expressed in cell lines primarily 
leads to an increase in intracellular Ca2+ concentration ([Ca2+]i), whereas activation of β-adrenergic-like OA receptors induces an increase in intracellular cAMP concentration 
([cAMP]i) but no increase in [Ca2+]i. Activation of the third-class Drosophila 
phenolamine receptor was shown to lead to both a reduction of [cAMP]i and generation 
of a Ca2+ signal. As OA and TA were equipotent in generating Ca2+ signaling, the 
third-class receptor was designated as the OA/TA receptor. However, members of the 
third receptor class, which have been identified to date from various insect species, were 
preferentially activated by TA to reduce [cAMP]i, so the OA/TA class of receptors is 
now thought to represent a class of TA receptors. 
 
Most of the OA receptors isolated so far belong to the class of α-adrenergic-like OA 
receptors. We have reported the cloning of an α-adrenergic-like OA receptor 
(BmOAR1) from the silkworm Bombyx mori. Agonist stimulation of BmOAR1 
increased both [Ca2+]i and [cAMP]i probably by activating the coupled Gq and Gs 
proteins, respectively. To date, however, only β-adrenergic-like OA receptors from D. 
melanogaster have been cloned. In the present study, we cloned a gene coding for a 
β-adrenergic-like OA receptor (hereafter designated as BmOAR2) from B. mori and 
generated a HEK-293 cell line that stably expressed BmOAR2 to compare the 
functional and pharmacological properties of the second β-adrenergic-like insect OA 
receptor with its Drosophila counterpart. 
 
A cDNA encoding a seven-transmembrane receptor (BmOAR2) was cloned from the 
nerve tissues of silkworm (Bombyx mori) larvae. Sequence analysis indicated that the 
gene is an ortholog of CG6989, which encodes a Drosophila β-adrenergic-like 
octopamine (OA) receptor (DmOctβ2R). As very little information is available 
regarding this class of receptors, I generated a cell line that stably expressed the gene in 
HEK-293 cells to perform functional and pharmacological studies of this receptor. 
[3H]OA-binding assays using membrane preparations of this cell line showed that the 
receptor possesses a higher affinity for OA than for tyramine (TA) or dopamine (DA). 
The cell line elicited a bell-shaped, OA concentration-dependent increase in intracellular 
cAMP levels, with a maximum at 100 nM. (R)-OA was more potent than (S)-OA. TA 
and DA had weak or marginal effects on cAMP production. The OA receptor agonist 
demethylchlordimeform elicited a similar biphasic response, and the maximum 
response was attained at a concentration as low as 1 nM. The rank order of potency of 
other agonists was as follows: naphazoline > tolazoline, clonidine, which is consistent 
with that of the classical type-2A OA receptors but not type-1 OA receptor, in which 
clonidine is the most potent agonist. Of the tested antagonists, only chlorpromazine 
significantly attenuated the OA-induced increase in cAMP levels, which showed that 
BmOAR2 pharmacologically resembles the classical type-1 OA receptors but not type-2 
OA receptors, for which chlorpromazine is a weak antagonist. However, phentolamine, 
which is one of the most potent type-1 OA receptor antagonists, had no antagonist effect 
on BmOAR2 but instead had weak agonist activity. No increase in intracellular Ca2+ 
levels was observed with OA at concentrations up to 100 μM. 
 
To identify the amino acid residues interacting with the intrinsic agonist (R)-OA in 
BmOAR2, the wild-type receptor and seven mutant receptors with an amino acid 
substitution at a potential orthosteric site were expressed in HEK-293 cells and 
examined for their abilities to elevate intracellular cAMP levels ([cAMP]i) in response 
to (R)-OA. The S206A mutant receptor retained the ability to increase [cAMP]i after 
(R)-OA treatment, although the stimulated cAMP level was lower than that of the 
wild-type receptor. In contrast, the other six mutant receptors (D115A, S202A, Y300F, 
Y300N, Y300L, and Y300A) lacked the ability to elevate [cAMP]i. These results 
indicate that D115, S202, and Y300 participate in (R)-OA binding and the activation of 
BmOAR2. Homology modeling and docking simulation studies suggest that S202 and 
Y300 interact with the phenolic OH group of (R)-OA, whereas D155 interacts with the β-OH group and the NH2 group of (R)-OA. 
 
 I employed the active metabolite DMCDM of the classical formamidine 
insecticide chlordimeform, which is an OA receptor agonist and leads to hyperactivity 
and death in insects, to clarify its pharmacological effect on HEK293-BmOAR2 cell 
lines. It was suggested that the change in [cAMP]i played a significant role in the 
insecticidal effect of DMCDM, rather than the change in [Ca2+]i, because DMCDM 
approximately 400-fold more selectively coupled to Gs protein-adenylate cyclase 
pathway to elevate intracellular cAMP levels, than Gq protein-phospholipase C-inositol 
triphosphate (IP3) pathway to generate increased levels of intracellular Ca2+ in 
BmOAR1. I found in this study that the maximal cAMP level induced by DMCDM was 
attained at a concentration 1 nM, and the EC50 value of DMCDM was estimated to be 
approximately  0.1 nM in HEK293-BmOAR2 cell line, while in the assay of DMCDM 
using HEK293-BmOAR1 cell line, the EC50 (mean ± S.E.) was 234 ± 48 nM and the 
maximal cAMP level in DMCDM was attained at a concentration 10 µM. Since 
DMCDM is much more potent in BmOAR2 than in BmOAR1, I suggest that the main 
target of chlordimerform might be β-adrenergic-like OARs. The cloned receptor 
described in this study is a β-adrenergic-like OA receptor with unique functional and 
pharmacological properties, and these studies on the orthosteric site of BmOAR2 should 
provide more opportunities to discover novel insect control chemicals. 
 
